https://www.facebook.com/timmileslaw/, Inc. Class Action Lawsuit The Kiromic BioPharma class action lawsuit seeks to represent purchasers or acquirers of Kiromic BioPharma, Inc. (NASDAQ: KRBP): (a) common stock pursuant to the registration statement filed and a final prospectus (together, the “Offering Documents”) issued in connection with Kiromic BioPharma’s public offering that closed on July 2, 2021 (the “Offering”); and/or (b) common stock between June 25, 2021 and August 13, 2021, inclusive (the “Class Period”). The Kiromic BioPharma class action lawsuit – captioned Karp v. Kiromic BioPharma, Inc., No. 22-cv-06690 (S.D.N.Y.) – charges Kiromic BioPharma, certain of its top executive officers and directors, as well as the successor to the Offering’s underwriter with violations of the Securities Act of 1933 and/or Securities Exchange Act of 1934. If you suffered losses in Kiromic BioPharma stock and wish to serve as lead plaintiff of the Kiromic BioPharma class action lawsuit, please provide your information below. You can also contact Kiromic BioPharma Stock Loss Lawyer Timothy L. Miles by calling 855/846-6529 or via e-mail at tmiles@timmileslaw.com. Lead plaintiff motions for the Kiromic BioPharma class action lawsuit must be filed with the court no later than October 4, 2022. If you suffered losses in Kiromic BioPharma and have questions, please contact Kiromic BioPharma Loss Lawyer Timothy L. Miles today. https://www.classactionlawyertn.com/kiromic-biopharma.html https://www.pinterest.com/tmiles676767/ https://www.facebook.com/timmileslaw/ https://www.linkedin.com/in/timothy-l-miles-79a69a32/ https://www.instagram.com/10k_law/ https://www.youtube.com/channel/UCbEh7RkQ94C6KVlZGubIYm @InvestFuture @Investment Insights #stockholding #shareholders #stoch @Bloomberg Markets and Finance @MARKET EXPLORE @SMART INVESTORS @Investor Network @Amazing Stock
from
https://www.youtube.com/watch?v=EVDjl5IGdKY
No comments:
Post a Comment